NCT03456960View on ClinicalTrials.gov

A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

October 10, 2018

Study Completion Date

October 12, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-438ASA

TAK-438ASA tablet.

DRUG

TAK-438

TAK-438 tablet.

DRUG

Aspirin

Aspirin enteric-coated tablet.

Trial Locations (1)

Unknown

Fukuoka Mirai Hospital, Fukuoka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03456960 - A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet | Biotech Hunter | Biotech Hunter